A new study reported that the presence of GOF mutations in PIK3CD does not impair BCR-induced AKT, mTOR and S6 phosphorylation, suggesting a useful confirmatory diagnostic test for APDS in the differential diagnosis from other CVID patients (50). The gene discussed is BCR; the disease is activated PI3K-delta syndrome.